We are Sorry, This Page doesn't Exist
Sarissa Capital reports 4.8% stake in Apricus Biosciences
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ideaya Biosciences price target raised to $38 from $31 at Roth Capital
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Ideaya Biosciences price target raised to $31 from $23 at Roth Capital
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Suvretta Capital reports 5.13% passive stake in Solid Biosciences
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Coherus Biosciences announces acceptance of BLA filing for CHS-1420
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
IGM Biosciences initiated with an Outperform at RBC Capital
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Catalyst Biosciences participates in a conference call with LifeSci Capital
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Home Point Capital announces filing of registration statement for proposed IPO
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
New Dimension Announces Financial Statement Filing Exemption
TSX-V: NDR VANCOUVER, Apri.....»»
Activist Investor Seeks Changes To YRC Board
In an amended 13D filing with the U.S. Securities and Exchange Commission, activist investor Barna Capital Group stated that it was moving forward wit.....»»
IGM Biosciences Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
- Initial data from Phase 1 trial of IGM-2323 in relapsed/refractory non-Hodgkin's lymphoma expected in the second half of 2020 - - IND filing for IGM-8444 planned in 2020 - - Company to host conference call today at 4:3.....»»
Ideaya Biosciences initiated with a Buy at Roth Capital
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Cellectar Biosciences stock dip "unwarranted," says Roth Capital
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
McClatchy downgraded to Market Perform after Chapter 11 filing at Noble Capital
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Tyro Capital 2019 Q4 Investor Letter
Below you can download Tyro Capital’s 2019 Q4 investor letter. Daniel HS McMurtrie’s Tyro Capital hasn’t started filing 1.....»»
Cellectar Biosciences transferred at Buy at Roth Capital
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Guoxuan says in talks with Volkswagen, hasn"t reached binding agreement
Guoxuan High-Tech Co Ltd is in talks with Volkswagen AG for potential strategic cooperation in technology, product, and capital, the Chinese battery maker wrote in a company filing on Monday......»»
APS parent company shuffles several C-suite positions
The parent company of the state's largest utility has shuffled its C-suite, according to a recent federal filing. Pinnacle West Capital Corp. (NYSE: PNW), the parent of Arizona Public Service Co., said Jan. 10 it had promoted three executives, acc.....»»
Third Point cuts its stake in Campbell Soup by 2.1 million shares
Daniel Loeb's hedge fund Third Point Capital sold off about 2.1 million shares of Campbell Soup Co. , according to a Securities and Exchange Commission filing l.....»»
Armistice Capital reports 5.7% passive stake in Scynexis
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»